Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications - Top-Institutions - MDSpire

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

  • By

  • Kenneth Tachi

  • Adwoa Agyei-Nkansah

  • Yacoba Atiase

  • Bright Forkuo

  • Victoria Akosua Agyen-Frimpong

  • July 2, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    UT Southwestern Medical Center
    UT Southwestern Medical Center

    Dallas, Texas

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Nutrition

  • #2

    Washington University School of Medicine in St. Louis & Barnes-Jewish Hospital
    Washington University School of Medicine in St. Louis & Barnes-Jewish Hospital

    St. Louis, Missouri

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Obesity Medicine

Original Source(s)

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

  • by Kenneth Tachi, Adwoa Agyei-Nkansah, Yacoba Atiase, Bright Forkuo, Victoria Akosua Agyen-Frimpong

  • July 2, 2026

Related Content

Revealing the pathogenesis of autoimmune hepatitis and research progress in drug discovery from hepatic immune cells and intercellular communication signaling mechanisms

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

Standardized Pre- and Early Postoperative Dietary Protocols After Bariatric and Metabolic Surgery: A 20-Year Single-Center Experience Across Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, and Ileal Procedures